中药注射剂的类过敏反应及其风险防控

梁爱华, 易艳, 张宇实, 韩佳寅, 田婧卓, 卢禹婷, 冯筱懿, 李春英

中国药学杂志 ›› 2015, Vol. 50 ›› Issue (15) : 1301-1308.

PDF(1460 KB)
PDF(1460 KB)
中国药学杂志 ›› 2015, Vol. 50 ›› Issue (15) : 1301-1308. DOI: 10.11669/cpj.2015.15.009
中药质量控制与安全性检测专栏

中药注射剂的类过敏反应及其风险防控

  • 梁爱华1, 易艳1, 张宇实1, 韩佳寅1, 田婧卓1, 卢禹婷1,2, 冯筱懿1,2, 李春英1
作者信息 +

Pseudoallergic Reactions of Traditional Chinese Medicine Injections and the Approaches for Risk Prevention and Control

  • LIANG Ai-hua1, YI Yan1, ZHANG Yu-shi1, HAN Jia-yin1, TIAN Jing-zhuo1, LU Yu-ting1,2, FENG Xiao-yi1,2, LI Chun-ying1
Author information +
文章历史 +

摘要

中药注射剂报道最多的不良反应是“过敏反应”,其症状包括皮肤黏膜红肿、瘙痒;腹痛、恶心;胸闷、呼吸困难以及血压下降等,严重时可发生休克或死亡。笔者通过对中药注射剂临床不良反应特点以及临床前实验研究结果的分析,提出中药注射剂的不良反应主要是以类过敏反应为主的观点。类过敏反应与过敏反应性质和产生机制不同,二者不宜混淆,否则会对临床应采取的处理措施以及基础研究方向产生误导。笔者还探讨了中药注射剂类过敏反应(PARs)风险防控途径。

Abstract

Allergic hypersensitivity reactions (AHRs) are the most commonly reported adverse reactions of traditional Chinese medicine injections, mainly including skin and mucosa redness, itching, abdominal pain, chest tightness, dyspnea and nausea, blood pressure decline, with clinical symptoms, and even shock or death In this paper, we analyzed the characteristics of clinical adverse reactions and preclinical study results of traditional Chinese medicine injections, and proposed a view of point that the main adverse reactions of traditional Chinese medicine injections are nonallergic hypersensitivity reactions (NHRs) or pseudoallergic reactions (PARs) instead of real AHRs Because there are absolute differences in the characteristics and the pathogenesis mechanisms between PARs and AHRs, they should not be confused, otherwise, the clinical processing measures and the direction of basic research on the adverse reactions of traditional Chinese medicine injections would be misleading This paper also discussed the approaches for risk prevention and control of PARs of traditional Chinese medicine injections.

关键词

中药注射剂 / 类过敏反应 / 过敏样反应 / 动物模型 / 不良反应

Key words

Chinese medicine injection / pseudoallergic reaction / anaphylactoid reaction / animal model / adverse reaction

引用本文

导出引用
梁爱华, 易艳, 张宇实, 韩佳寅, 田婧卓, 卢禹婷, 冯筱懿, 李春英. 中药注射剂的类过敏反应及其风险防控[J]. 中国药学杂志, 2015, 50(15): 1301-1308 https://doi.org/10.11669/cpj.2015.15.009
LIANG Ai-hua, YI Yan, ZHANG Yu-shi, HAN Jia-yin, TIAN Jing-zhuo, LU Yu-ting, FENG Xiao-yi, LI Chun-ying. Pseudoallergic Reactions of Traditional Chinese Medicine Injections and the Approaches for Risk Prevention and Control[J]. Chinese Pharmaceutical Journal, 2015, 50(15): 1301-1308 https://doi.org/10.11669/cpj.2015.15.009
中图分类号: R283   

参考文献

[1] DESCOTES J. Immunotoxicology, role in the safety assessment of drugs. Drug Safety,2005,28(2):127-136.
[2] DESCOTES J,CHOQUET-KASTYLEVSKY G. Gell and Coombs′s classification: Is it still valid. Toxicology,2001,158(1-2):43-49.
[3] LI J. Analysis of 56 cases ADRs caused by Shuanghuanglian injection . China Foreign Med Treat(中外医疗),2010,7(7):125-126.
[4] CHEN W. Clinical analysis of 38 cases of adverse drug reaction caused by Shuanghuanglian Powder Injection . Clin Focus (临床荟萃),2003,18(3):169.
[5] WANG J. Analysis of 53 cases of adverse drug reaction caused by Shuanghuanglian Injection . Public Med Forum Magazine (基层医学论坛),2008,12:512-512.
[6] DONG F Q,ZHANG J,ZHAO Y. Retrospective investigation of ADRs caused by Shuanghuanglian Injection . Chin Med Guides (中国医药导报),2007,4(21):84-85.
[7] GONG T,LIU Y,ZHANG B L. Analysis of 310 cases of adverse drug reaction caused by Shuanghuanglian Injection . J Tianjin Univ Tradi Chin Med (天津中医药学院学报),2003,22(1):49-50.
[8] CHEN M L. Retrospective analysis of 63 cases of adverse drug reactions/events induced by Shenmai Injection .J China Pharm(中国药房),2013,24(48):4531-4533.
[9] XU G N,SHEN P H,LI X Y. Analysis of 113 cases of severe adverse drug reaction caused by Mailuoning Injection . Zhejiang J Integr Tradi Chin Western Med(浙江中西医结合杂志),2007,17(9):594-595.
WANG Y,GUO P,SHANG H C,et al. Literature analysis on 560 cases of adverse drug reactions/events of Astragalus Injection. J Tradi Chin Med(中医杂志),2011,52(9):779-783.
LIN Q,ZHANG S. Analysis of 270 cases of adverse drug reactions/events reports caused by Xiyanping Injection. Chin J Pharmacovigil (中国药物警戒),2012,9(12):751-754.
LI M H,MA L,CHEN L J,et al. The clinical analysis of adverse effects of Yinzhihuang Injection . Drug Evaluation (药品评价),2006,3(5):355-357.
LI W W,XIA X D,ZHANG H X. Analysis of 962 ADR/ADE cases of Mailuoning Injection .J China Pharm(中国药房),2010,21(24):2263-2265.
ZHAO W,ZHANG Y L,ZHENG L,et al. Analysis of 588 cases of ADRs caused by Xiangdan Injection reported in 2067 articles . Henan Tradi Chin Med(河南中医),2011,31(3):298-302.
HU J,SHANG H C,LI J,et al. 521 Cases of adverse drug reactions of Ciwujia Injection based on 2944 studies . Chin J Evid-based Med (中国循证医学杂志),2010,10(2):182-188.
HAO Y,KONG X Y,WU T X. Assessment of the safety of Qingkailing Injection: A systematic review . Chin J Evid-based Med (中国循证医学杂志),2010,10(2):162-175.
GUAN X,XU D S. Literature analysis of anaphylactic shock caused by Shengmai Injection . Chin J Pharmacoepidemiol (药物流行病学杂志),2013,22(1):43-45.
XU J,LUO L,WANG S S. Analysis of 21 anaphylactic shock reports induced by Huangqi Injection. J China Pharm(中国药房),2011,22(32):3030-3031.
CHEN Y Q. Literature analysis of anaphylactic shock caused by Mailuoning Injection .J China Pharm(中国药房),2012,23(4):336-338.
WANG L N. Analysis of 66 cases of allergic shock caused by Shuanghuanglian Injection . Eval Anal Drug Hosp China(中国医院用药评价与分析),2010,10(4):368-370.
ZHANG Q. Epidemiological characteristics of anaphylactic shock caused by acanthopanac is senticosi . Chin J Mod Drug Appl(中国现代药物应用),2008,2(11):21-24.
ZENG C Y,WU F R,UANG M Y. Literature analysis of 85 cases of anaphylactic shock induced by Qingkailing Injection . Chin Arch Tradit Chin Med (中华中医药学刊),2014,32(8):1919-1923.
YAN G Y,BU Q,CEN X B. Non-clinical safety evaluation approaches applied to traditional Chinese medicine injection. Chin J Pharmacovigil (中国药物警戒),2011,8(3):161-164.
National Center for ADR Monitoring.Adverse drug reaction information bulletin. . http://www.cdr.gov.cn/xxtb_255/ypblfyxxtb/
CFDA. Annual report of the national adverse drug reaction monitoring (2013) . .http://www.sda.gov.cn/WS01/CL0078/99794.html
XIE J,WANG J C,WANG A W. Safety evaluation of three traditional Chinese medicine injections. Chin J Exp Tradit Med Form(中国实验方剂学杂志),2013,19(16):263-267.
JIAN B P,TIAN L,FANG H,et al. Allergenicity reevaluation of several traditional Chinese medicine injections which can cause the type I hypersensitivity in clinical practice . Anhui Med Pharm(安徽医药),2014,18(1):20-21.
LIU X J,LIAO R F,JIANG Q T,et al. Hypersusceptibility study of Mailuoning Qingkailing and Xiangdan Injections in quinea pigs . Chin J Hosp Pharm (中国医院药学杂志),2014,34(3):186-189.
XIANG Z,ZHANG J F,XIAO H,et al. Research in acute hypersensitive reaction caused by Xuesaitong Injection.Chin J Mod Appli Pharm(中国现代应用药学),2012,29(9):768-771.
HUANG C G,MO Z C,WU S L,et al. Effect of traditional Chinese medicine injections on allergic reactions . World Sci Tech Mod Tradit Chin Med(世界科学技术-中医药现代化),2014,16(4):886-889.
ZHANG D,QU Z,HUO G T,et al. Research progress in preclinical safety evaluation on hypersensitivity induced by traditional Chinese medicine . Drug Eval Res (药物评价研究),2013,36(4):241-244.
SONG Y,FU J F. Study of allergy test method of Huangqi Injection. Heilongjiang Med J(黑龙江医药),2011,24(5):723-724.
CHEN X K,SU X B,DAI W W,et al. Experimental comparison on acute toxicity and allergy test of Chuanhuning Injections . Pharmacol Clin Chin Mater Med(中药药理与临床),2005,21(5):17-18.
LIANG A,YI Y,LI C,et al. Methodology for preclinical assay of pseudoallergy of injectable drugs(I):Mouse model for assay of pseudoallergy induced by injections. China J Chin Mater Med(中国中药杂志),2012,37(13):1865-1868.
LI C Y,LIANG A H,GAO S R,et al. Development of animal model for anaphylactoid test of rodent . China J Chin Mater Med(中国中药杂志),2011,36(4):488-491.
MILES A A, MILES E M. Vascular reactions to histamine, histamineliberator and leukotaxine in the skin of guinea-pigs. J Physiol,52,8:228-257.
LIANG A H,ZHAO Y,LI C Y,et al. Methodology for preclinical assay of pseudoallergy of injectable drugs(I):Rat model for assay of cutaneous pseudoallergy induced by injections . China J Chin Mater Med(中国中药杂志),2012,37(13):1871-1874.
LIANG A H,LI C Y,HAO R,et al. Anaphylactoid reaction analysis of Chinese herbal injections in Beagle dogs . China J Chin Mater Med(中国中药杂志),2010,17(35):2328-2333.
HE P,LI F J,TANG R M,et al. Experimental study on anaphylactoid reactions induced by different components of Shengmai Injection on Beagle dogs . China J Chin Mater Med(中国中药杂志),2012,37(13):1880-1883.
HE Y L,YI Y,WANG H X,et al. Study on anaphylactoid reactions induced by Tween 80-containing Chinese medicine injection in Beagle dogs . Parmacol Clin Chin Mater Med(中药药理与临床),2005,21(1):55-56.
GENG X C,SONG Y,ZHANG L,et al. Anaphylactoid study for Polysorbate 80 made by different production technique in Beagle dogs . Chin Phara Aff(中国药事),2011,25(10):982-984.
WANG Z G,WANG D Q,WU Z E,et al. Experimental study on the anaphylactoid reaction induced by Qingkailing Injections on the Beagle dogs . J Tradit Chin Med (中医杂志),2010,51(4):362-364.
SZEBENI J. Complement activation-related pseudoallergy: A new class of drug-induced acute immune toxicity . Toxicology,2005,216(2-3):106-121.
SZEBENI J,ALVING C R,ROSIVALL L,et al. Animal models of complement-mediated hypersensitivity reactions to liposomes and other lipid-based nanoparticles . J Liposome Res,2007,17(2):107-117.
SZEBENI J,BEDOCS P,ROZSNYAY Z,et al. Liposome-induced complement activation and related cardiopulmonary distress in pigs: Factors promoting reactogenicity of Doxil and AmBisome . Nanomedicine,2012,8(2):176-184.
SZEBENI J,MUGGIA F M,ALVING C R. Complement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: An in vitro study . J Natl Cancer Inst,1998,90(4):300-306.
ENNIS M,NEHRING E,SCHNEIDER C. Adverse reactions to drugs: In vitro studies with isolated cells. Inflamm Res,2004,53(2);S105-S108.
CHANAN K,SZEBENI J,SAVAY S,et al. Complement activation following first exposure to pegylatedliposomal doxorubicin (Doxil?): Possible role in hypersensitivity reactions. Ann Oncol,2003,14(9):1430-1437.
ZHANG J,LI Y K,LI L D,et al. The role of complement activation on Tween 80-induced anaphylactoid reactions . J Toxicol (毒理学杂志),2009,23(6):457-459.
DENG X L,ZHU Y H,WANG Q, et al. Analysis of anaphylactoid reactions caused by TCMIs via detection of histamine release in primary mast cells . Chin J Exp Tradit Med Form(中国实验方剂学杂志),2013,19(21):271-275.
YAN W J,LI L D,ZHANG M Y,et al. Anaphylactoid reaction study of seven Chinese medicine injections . Chin J New Drugs (中国新药杂志),2010,19(20):1895-1910.
YI Y,LIANG A H,ZHAO Y,et al. Material and mechanisms for evaluation of Shuanghuanglian injection induced pseudoallergic reactions . China J Chin Mater Med(中国中药杂志), 2011,36(14):1865-1869.
ZHANG J,LI Y K,LI L D,et al. The role of complement activation on Tween 80-induced anaphylactoid reactions . J Toxicol(毒理学杂志),2009,23(6):457-459.
LIU T,ZHAO Y,CAO C,et al. Material and mechanisms Induced pseudoallergic reactions of Yuxingcao injection . China J Chin Mater Med(中国中药杂志),2010,35(12):1603-1606.
CUI H Y,YI Y,LI C Y,et al. Experimental study on pseudoallergic reaction of Qingkailing Injection . China J Chin Mater Med(中国中药杂志),2014,39(3):511-514.
YI Y,LIANG A H,LI C Y,et al. Relationship between specific immunocyte and pseudoanaphylactoid reactions induced by Shuanghuanglian Injection . China J Chin Mater Med(中国中药杂志),2012,37(13):1898-1900.
WANG Y T,LI C Y,YI Y,et al. Comparative study on anaphylactoid reactions induced by medicinal tween 80 and injectable tween 80 . China J Chin Mater Med(中国中药杂志),2012,37(13):1890-1893.
CFDA. Notice of 7 technical guidelines on the safety of Chinese medicine injection. . http://www.sda.gov.cn/WS01/CL0058/54917. html
CHENG M,JIANG K H,HUANG P. 1012 Cases of adverse reactions/event of Shengmai Injections . Anhui Med Pharm J (安徽医药),2011,15(2):250-253.
LI W H,XING J H,CHEN F F. Analysis of 146 of adverse drug reactions by Shengmai Injection . Strait Pharm J(海峡药学),2011,23(12):247-248.
YANG Y N,FENG X M,HE H M,et al. Analysis of 144 of adverse drug reactions/events by Shuanghuanglian Injection . J Guangdong Pharm Univ(广东药学院学报),2014,30(2):210-213.
JI L W,LI J H,LIN X,et al. Evaluation of the rationality and safety of Shuxuening Injection in 212 outpatients . Chin Pharm J (中国药学杂志),2014,49(1):76-79.
ZHANG P H,XIAO M S,ZHANG J,et al. The investigation of the insolubie particles of the Shuxuening Injection with five kinds of infusions . Chin Pharm(中国药师),2009,12(2):259-260.
LIANG L M,PENG J,LIAO G J,et al. The investigation of the insolubie particles of the Shuxuening Injection with infusion . J Chin Med Mater (中药材),2012,35(6):994-996.
LI T Q,LIU X M,FENG M,et al. Systematic review on the application and adverse reactions of Shengmai Injection . Chin J Integr Trad West Med (中国中西医结合杂志),2009,29(11):965-967.
LI Y J. Analysis of 327 of adverse drug reactions by Shuanghuanglian Injection . Prac Phar Clin Remedy (实用药物与临床),2008,11(1):35,62-62.
SUN S G,LI Z F,XIE Y M,et al. Analysis of rational clinical uses of traditional Chinese medicine injections and factors influencing adverse drug reactions. China J Chin Mater Med(中国中药杂志),2013,18(38):2970-2973.
FU Z,CHEN L,LIANG J Z. Adverse drug reaction induced by Shengmai Injection . China Pharmacist(中国药师),2009,12(12):1798-1800.
LI W W,ZHANG H X,YANG S S,et al. Analysis of 631 reports of ADR/ADE caused by Xuesaitong Injection . Chin J Pharm(中国药物警戒),2010,7(11):690-693.
XU C L,SUN Y,DING L P,et al. Analysis of severe ADRs caused by infusion of Fufang Danshen Injection in combination with low molecular Dextran . Chin J Drug Abuse Preven (中国药物滥用防治杂志),2008,14(6):361-364.
LI L,ZHANG S Q. Analysis of the occurrence time and severity of phlebitis caused by Chinese medicine injection . Beijing J Tradit Chin Med (北京中医药),2013,32(1):74-77.
MIN H Q. Analysis on infusion of Chinese medicine injection in combination with antibiotics . Strait Pharm J (海峡药学),2009,21(3):147-148.
WAND P,XU Y G, ZHU L Q,et al. The influence of the intervention with drug combination and dosage associated with the traditional Chinese medicine injections . Chin J Hosp Pharm(中国医院药学杂志),2008,28(12):997-999.

基金

国家重大新药创制专项(2015ZX09501004);国家自然科学基金资助项目(81374057);中国中医科学院自主选题(2014年)

PDF(1460 KB)

Accesses

Citation

Detail

段落导航
相关文章

/